Dermal Cell News Volume 9.35 | Oct 30 2023

    0
    14








    2023-10-30 | DCN 9.35


    Dermal Cell News by STEMCELL Technologies
    Vol. 9.35 – 30 October, 2023
    TOP STORY

    Single-Atom Catalysts-Based Catalytic ROS Clearance for Efficient Psoriasis Treatment and Relapse Prevention via Restoring ESR1

    Scientists showed that biomimetic iron single-atom catalysts with broad-spectrum reactive oxygen species (ROS) scavenging capability could be used for psoriasis treatment and relapse prevention via related gene restoration.
    [Nature Communications]

    Full Article
    She wanted to join the battle against cancer. So she started a company. Read Sofie Pattijn's story.
    PUBLICATIONSRanked by the impact factor of the journal

    Mechanical Stimulation of Human Hair Follicle Outer Root Sheath Cultures Activates Adjacent Sensory Neurons

    Using electrochemical analysis on human hair follicle preparations in vitro, researchers were able to show that outer root sheath cells released ATP and the neurotransmitters serotonin and histamine in response to mechanical stimulation.
    [Science Advances]

    Full ArticlePress Release

    Bioengineered Skin Constructs Based on Mesenchymal Stromal Cells and Acellular Dermal Matrix Exposed to Inflammatory Microenvironment Releasing Growth Factors Involved in Skin Repair

    The authors developed a novel method involving physicochemical and enzymatic treatment of cadaveric human skin to obtain human acellular dermal matrix scaffold.
    [Stem Cell Research & Therapy]

    Full Article

    Hypoxic Microenvironment Promotes Dermal Fibroblast Migration and Proliferation via a BNIP3-Autophagy Pathway

    Using previously established mouse full-thickness wounds, scientists showed that Bcl-2 and adenovirus E1B 19-kDa interacting protein 3 (BNIP3) expression was significantly elevated at the wound edge, and hypoxia treatment enhanced BNIP3 expression in fibroblasts.
    [FEBS Journal]

    Abstract

    A Human Mucosal Melanoma Organoid Platform for Modeling Tumor Heterogeneity and Exploring Immunotherapy Combination Options

    The authors addressed the lack of cell models for mucosal melanoma by establishing 30 organoids of human oral mucosal melanoma, which retained major histopathological and functional features of parental tumors
    [Science Advances]

    Full Article

    Transglutaminase Type 2-MITF Axis Regulates Phenotype Switching in Skin Cutaneous Melanoma

    Researchers discovered a key function of Transglutaminase Type-2 in regulating melanogenesis by modulating MITF transcription factor expression and its transcriptional activity.
    [Cell Death & Disease]

    Full ArticleGraphical Abstract

    Discovery of 3-Phenyl Indazole-Based Novel Chemokine-Like Receptor 1 Antagonists for the Treatment of Psoriasis

    In the imiquimod-induced psoriasis-like mouse model, oral administration of the optimized compound for one week significantly alleviated modified psoriasis area and severity index scores, compared with the control group.
    [Journal Of Medicinal Chemistry]

    Abstract

    The JAK/STAT/NF-κB Signaling Pathway Can Be Regulated by Rosemary Essential Oil, Thereby Providing a Potential Treatment for DNCB-Induced in Mice

    A dinitrochlorobenzene (DNCB)-induced atopic dermatitis mouse model was established and treated with low, medium, and high doses of Rosmarinus officinalis essential oil.
    [Biomedicine & Pharmacotherapy]

    Full ArticleGraphical Abstract

    Liquiritin Targeting Th17 Cells Differentiation and Abnormal Proliferation of Keratinocytes Alleviates Psoriasis via NF-κB and AP-1 Pathway

    HaCaT cells were stimulated by TNF-α with or without liquiritin, harvested for analysis by western blots and RT-qPCR, and the cellular supernatants were collected and analyzed by ELISA for cytokines.
    [Phytotherapy Research]

    Abstract
    Facts Vs. claims. Three scientists peer reviewed a life science vendor to get to the truth. See for yourself.
    REVIEWS

    The Role of NLRP1 Inflammasome in Skin Cancer and Inflammatory Skin Diseases

    The authors shed light on the implications of pathological dysregulation of the NLRP1 inflammasome in skin diseases and investigate the potential rationale for targeting this pathway as a future therapeutic approach.
    [British Journal Of Dermatology]

    Abstract

    Proteolytic and Antiproteolytic Activity in the Skin: Gluing the Pieces Together

    Deciphering the genetic basis of a number of inherited conditions has delineated the pivotal role played in this process by a series of proteases and protease inhibitors, including serpins, cathepsins, and cystatins, suggesting novel avenues for therapeutic intervention in both rare and common disorders of cornification.
    [Journal Of Investigative Dermatology]

    Abstract
    INDUSTRY AND POLICY NEWS

    SparX Biopharmaceutical Announces FDA Greenlight for IND Application of SPX-303, A First-In-Human anti-LILRB2/PD-L1 Antibody Drug

    The company is primed to launch a Phase I clinical study, aiming to assess the safety, tolerability, and preliminary efficacy of SPX-303 in patients beleaguered by advanced or refractory solid tumors.
    [SparX Biopharmaceutical Corp. (Cision Newswire)]

    Press Release
    FEATURED EVENT

    Cell Bio 2023

    December 2 – 6, 2023
    Boston, Massachusetts, United States

    > See All Events

    JOB OPPORTUNITIES

    Scientist/Physician-Scientist – Dermatology

    UC San Diego – San Diego, California, United States

    Postdoctoral Scientist – Skin Cancer and Aging

    Cancer Research UK Manchester Institute – Manchester, England, United Kingdom

    Postdoctoral Fellow – Cancer Research

    University of Gothenburg – Gothenburg, Sweden

    Clinical Research Coordinator – Rheumatology

    Cedars-Sinai – Los Angeles, California, United States

    Scientific Director – Intramural Research Program

    National Cancer Institute – Bethesda, Maryland, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Dermal Cell News Twitter